Literature DB >> 9501175

A genetic screen for the isolation and characterization of site-specific proteases.

H J Sices1, T M Kristie.   

Abstract

Site-specific proteolysis is an important regulatory mechanism in basic cellular and viral processes. Using the protease of the HIV as a model, a genetic system has been developed for the isolation and characterization of site-specific proteases. The system utilizes the well defined bacteriophage lambda regulatory circuit where the viral repressor, cI, is specifically cleaved to initiate the lysogenic-to-lytic switch. The model system is rapid, highly specific, and demonstrates the ability to isolate and characterize enzymes of limited expression or activity. In addition, the system has a significant potential for the selection of clinically relevant mutant enzymes and in the development of anti-protease therapeutics.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9501175      PMCID: PMC19654          DOI: 10.1073/pnas.95.6.2828

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  43 in total

Review 1.  Notch signaling.

Authors:  S Artavanis-Tsakonas; K Matsuno; M E Fortini
Journal:  Science       Date:  1995-04-14       Impact factor: 47.728

Review 2.  Processing of retroviral Gag polyproteins: an in vitro approach.

Authors:  C Carter; G Zybarth
Journal:  Methods Enzymol       Date:  1994       Impact factor: 1.600

Review 3.  Specificity of retroviral proteases: an analysis of viral and nonviral protein substrates.

Authors:  A G Tomasselli; R L Heinrikson
Journal:  Methods Enzymol       Date:  1994       Impact factor: 1.600

4.  Analysis of human immunodeficiency virus type 1 protease activity in eukaryotic and bacterial cells.

Authors:  A H Kaplan; M Manchester; L Everitt; R Swanstrom
Journal:  Methods Enzymol       Date:  1994       Impact factor: 1.600

Review 5.  Genetic approaches designed to minimize cytotoxicity of retroviral protease.

Authors:  C J Rizzo; B D Korant
Journal:  Methods Enzymol       Date:  1994       Impact factor: 1.600

Review 6.  Expression systems for retroviral proteases.

Authors:  J Stebbins; C Debouck
Journal:  Methods Enzymol       Date:  1994       Impact factor: 1.600

Review 7.  Mechanisms and genes of cellular suicide.

Authors:  H Steller
Journal:  Science       Date:  1995-03-10       Impact factor: 47.728

8.  Characterization of a soluble, catalytically active form of Escherichia coli leader peptidase: requirement of detergent or phospholipid for optimal activity.

Authors:  W R Tschantz; M Paetzel; G Cao; D Suciu; M Inouye; R E Dalbey
Journal:  Biochemistry       Date:  1995-03-28       Impact factor: 3.162

9.  SREBP-1, a membrane-bound transcription factor released by sterol-regulated proteolysis.

Authors:  X Wang; R Sato; M S Brown; X Hua; J L Goldstein
Journal:  Cell       Date:  1994-04-08       Impact factor: 41.582

10.  Autoproteolysis in hedgehog protein biogenesis.

Authors:  J J Lee; S C Ekker; D P von Kessler; J A Porter; B I Sun; P A Beachy
Journal:  Science       Date:  1994-12-02       Impact factor: 47.728

View more
  15 in total

1.  Autocatalytic proteolysis of the transcription factor-coactivator C1 (HCF): a potential role for proteolytic regulation of coactivator function.

Authors:  J L Vogel; T M Kristie
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-15       Impact factor: 11.205

2.  Sensitive genetic screen for protease activity based on a cyclic AMP signaling cascade in Escherichia coli.

Authors:  N Dautin; G Karimova; A Ullmann; D Ladant
Journal:  J Bacteriol       Date:  2000-12       Impact factor: 3.490

3.  HIV protease-activated molecular switches based on beta-glucuronidase and alkaline phosphatase.

Authors:  Taryn L O'Loughlin; Ichiro Matsumura
Journal:  Comb Chem High Throughput Screen       Date:  2006-05       Impact factor: 1.339

4.  Rapid assessment of phenotypic resistance to protease inhibitors in human immunodeficiency virus type 1 group O.

Authors:  Berta Rodés; Eva Poveda; Vincent Soriano
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

5.  A bacteriophage lambda-based genetic screen for characterization of the activity and phenotype of the human immunodeficiency virus type 1 protease.

Authors:  M A Martínez; M Cabana; M Parera; A Gutierrez; J A Esté; B Clotet
Journal:  Antimicrob Agents Chemother       Date:  2000-05       Impact factor: 5.191

6.  Cell-based fluorescence assay for human immunodeficiency virus type 1 protease activity.

Authors:  K Lindsten; T Uhlíková; J Konvalinka; M G Masucci; N P Dantuma
Journal:  Antimicrob Agents Chemother       Date:  2001-09       Impact factor: 5.191

7.  A yeast-based growth assay for the analysis of site-specific proteases.

Authors:  Fabian Köhler
Journal:  Nucleic Acids Res       Date:  2003-02-15       Impact factor: 16.971

8.  Genetic screen for monitoring severe acute respiratory syndrome coronavirus 3C-like protease.

Authors:  Mariona Parera; Bonaventura Clotet; Miguel Angel Martinez
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

9.  A cloning method to identify caspases and their regulators in yeast: identification of Drosophila IAP1 as an inhibitor of the Drosophila caspase DCP-1.

Authors:  C J Hawkins; S L Wang; B A Hay
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

10.  Model system for high-throughput screening of novel human immunodeficiency virus protease inhibitors in Escherichia coli.

Authors:  Ting-Jen Cheng; Ashraf Brik; Chi-Huey Wong; Chen-Chen Kan
Journal:  Antimicrob Agents Chemother       Date:  2004-07       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.